Skip to main content
Log in

Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Leukotriene B4 (LTB4) is a proinflammatory product of arachidonic acid metabolism that has been implicated as a mediator in a number of inflammatory diseases. When injected intradermally into the cavine, LTB4 elicits a dose-dependent immigration (chemotaxis) of neutrophils (PMNs) into the injection sites as assessed by the presence of a neutrophil marker enzyme myeloperoxidase. SC-41930 {7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-l-benzopyran-2-carboxylic acid, a potent LTB4 receptor antagonist inhibited the chemotactic actions of LTB4 when coadministered into the dermal site and when given intravenously or orally with ED50 values of 200 ng, 0.5 mg/kg, and 0.6 mg/ kg respectively. This compound may well have application in disease states, such as inflammatory bowel disease and psoriasis, where LTB4 is implicated as a proinflammatory mediator.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Plamblad, J., C. Malmsten, A. Uden, O. Radmark, L. Engstrot, andB. Samuelson. 1981. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence.Blood 58:658–661.

    Google Scholar 

  2. Redl, H., P. Flynn, H. Lamche, A. Schiesser, G. Schlag, andD. Hammerschmidt. 1983. Aggregation, chemotaxis and chemiluminesence of canine granulocytes.Inflammation 7:67–79.

    Google Scholar 

  3. Ford-Hutchison, A., M. Bray, M. Doig, M. Shipley, andM. Smith. 1980. Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukoctyes.Nature 286:264–265.

    Google Scholar 

  4. Hoover, R., M. Karnovsky, K. Austin, E. Corey, andR. Lewis. 1984. Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion.Proc. Natl. Acad. Sci. U.S.A. 81:2191.

    Google Scholar 

  5. Czarnetzki, B., andR. Mertensmeir. 1985. In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and itsω-oxidation products.Prostaglandins 30:5–11.

    Google Scholar 

  6. Colditz, I., andH. Movat. 1984. Kinetics of neutrophil accumulation in accute inflammatory lesions induced by chemotaxis and chemotaxinigens.J. Immunol. 133:2169–2173.

    Google Scholar 

  7. Bhattacherjee, P., B. Hammond, J. Salmon, R. Stepney, andK. Eakins. 1981. Chemotactic response to some arachidonic acid lipoxygenase products in the rabbit eye.Eur. J. Pharmacol. 73:21–28.

    Google Scholar 

  8. Camp, R., A. Coutts, M. Greaves, A. Kay, andM. Walport. 1983. Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.Br. J. Pharmacol. 8:497–502.

    Google Scholar 

  9. Soter, N., R. Lewis, E. Corey, andK. F. Austin. 1983. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin.J. Invest. Dermatol. 80:115–119.

    Google Scholar 

  10. Keith, R., W. Smith, B. Tsai, S. Levin, andG. Butchko. 1985. Myeloperoxidase activity in experimentally induced colitis.Fed. Proc. 44:1545.

    Google Scholar 

  11. Krawisz, J., P. Sharon, andW. Stenson. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity.Gastroenterology 87:1344–1350.

    Google Scholar 

  12. Bradley, P., D. Priebat, R. Christensen, andG. Rothstein. 1982. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker.J. Invest. Dermatol. 78:206–209.

    Google Scholar 

  13. Fretland, D., S. Levin, B. Tsai, S. Djurić, D. Widomski, J. Zemaitis, R. Shone, andR. Bauer. 1989. The effect of a leukotriene-B4 receptor antagonist, SC-41930, on acetic acidinduced colonie inflammation.Agents Actions 27:225–227.

    Google Scholar 

  14. Smith, W., B., Cohen, S. Levin, andG. Butchko. 1986. In vivo chemotaxis to leukotriene-B4 detected by meyloperoxidase activity.Fed. Proc. 45:63.

    Google Scholar 

  15. Sharon, P., andW. Stenson. 1984. Enhanced synthesis of leukotriene-B4 by colonie mucosa in inflammatory bowel disease.Gastroenterology 86:453–460.

    Google Scholar 

  16. Ziboh, V., T. Casebolt, C. Marcelo, andJ. Voorhees. 1984. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.J. Invest. Dermatol. 83:426–430.

    Google Scholar 

  17. Brain, S., R. Camp, P. Dowd, A. Kobza-Black, andM. Greaves. 1984. The release of leukotriene-B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.J. Invest. Dermatol. 83:70–73.

    Google Scholar 

  18. Lucchesi, B., andK. Mullane. 1986. Leukocytes and ischemia-induced myocardial injury.Annu. Rev. Pharmacol. Toxicol. 26:201–224.

    Google Scholar 

  19. Mullane, K. 1988. Eicosanoids in myocardial ischemia/reperfusions injury.Adv. Inflammation Res. 12:191–214.

    Google Scholar 

  20. Aked, D., andS. Foster, 1987. Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid.Br. J. Pharmacol. 92:545–552.

    Google Scholar 

  21. McMillan, R., andS. Foster, 1988. Leukotriene B4 and inflammatory disease.Agents Actions 24:114–119.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fretland, D.J., Widomski, D.L., Zemaitis, J.M. et al. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis. Inflammation 13, 601–605 (1989). https://doi.org/10.1007/BF00916766

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00916766

Keywords

Navigation